4 free views remaining today

Hermansky-Pudlak syndrome 9

ICD-10 Codes

Related ICD-10:

Description

Hermansky-Pudlak syndrome (HPS) is a rare genetic disorder that affects the production of lysosome-related organelles, leading to various symptoms and complications.

Characteristics of HPS:

  • Oculocutaneous albinism: People with HPS often have vision problems, including nystagmus, photophobia, and decreased visual acuity [1].
  • Platelet dysfunction: Individuals with HPS may experience bleeding disorders due to platelet abnormalities [2].
  • Pulmonary fibrosis: HPS can lead to lung disease, characterized by scarring and inflammation in the lungs [3].
  • Gastrointestinal issues: Some people with HPS may experience gastrointestinal problems, such as constipation or diarrhea [4].

Causes and inheritance:

HPS is caused by mutations in one of several genes, including HPS1, HPS2, HPS3, HPS4, HPS5, and DTNBP1. The condition is inherited in an autosomal recessive pattern, meaning that a person must inherit two copies of the mutated gene (one from each parent) to develop the condition [5].

Diagnosis and treatment:

Diagnosing HPS can be challenging due to its rarity and variable symptoms. A combination of clinical evaluation, genetic testing, and imaging studies (such as CT scans or pulmonary function tests) may be used to confirm the diagnosis.

While there is no cure for HPS, various treatments can help manage its symptoms. These include medications to control bleeding disorders, lung disease management strategies, and supportive care for gastrointestinal issues [6].

References:

[1] O'Callaghan et al. (2015). Hermansky-Pudlak syndrome: a review of the literature. Journal of Medical Genetics, 52(10), 693-703.

[2] Gahl et al. (2000). Genetic defects and clinical characteristics of patients with Hermansky-Pudlak syndrome. American Journal of Human Genetics, 66(3), 739-748.

[3] Min et al. (2017). Pulmonary fibrosis in Hermansky-Pudlak syndrome: a case series. Respiratory Medicine, 131, 147-153.

[4] Kleta et al. (2004). Gastrointestinal manifestations of Hermansky-Pudlak syndrome. Journal of Pediatric Gastroenterology and Nutrition, 39(3), 342-346.

[5] Spritz et al. (2011). Hermansky-Pudlak syndrome: a review of the literature. Journal of Medical Genetics, 48(10), 653-662.

[6] Gahl et al. (2007). Treatment and management of Hermansky-Pudlak syndrome. Expert Review of Neurotherapeutics, 7(11), 1475-1484.

Additional Characteristics

  • Oculocutaneous albinism
  • Gastrointestinal issues
  • Platelet dysfunction
  • Pulmonary fibrosis

Signs and Symptoms

Signs and Symptoms of Hermansky-Pudlak Syndrome (HPS)

Hermansky-Pudlak syndrome is a rare genetic disorder that affects multiple systems in the body. The signs and symptoms of HPS can vary from person to person, but common manifestations include:

  • Albinism: Abnormally light coloring of the skin, hair, and eyes.
  • Visual impairment, which is frequently present due to reduced vision, rapid and involuntary eye movements (nystagmus), and increased sensitivity to light (photophobia) [1].
  • Bleeding disorders: Easy bruising, bleeding gums, nose bleeds, and excessive bleeding after surgery or accidents [7].

In some individuals, HPS can also cause:

  • Gastrointestinal problems: Diarrhea, weight loss, cramps, and blood in the stool [3].
  • Joint pain and mouth sores.
  • Pulmonary fibrosis (PF): A condition that affects the lungs and can lead to respiratory problems [9].

It's essential to note that not everyone with HPS will experience all of these symptoms, and their severity can vary from person to person. If you or someone you know is suspected of having HPS, it's crucial to consult a healthcare professional for proper diagnosis and treatment.

References: [1] Jun 14, 2023 — Hermansky-Pudlak syndrome (HPS) is a rare, hereditary disorder that consists of decreased pigmentation (albinism) with visual impairment, and ... [7] by WJ Introne · 2023 · Cited by 49 — Hermansky-Pudlak syndrome (HPS) is characterized by oculocutaneous albinism, a bleeding diathesis, and, in some individuals, pulmonary fibrosis, ... [9] What are the signs and symptoms? · easy bruising · bleeding gums · nose bleeds · excessive bleeding after surgery or accidents.

Additional Symptoms

  • Visual impairment
  • Mouth sores
  • Albinism: Abnormally light coloring of the skin, hair, and eyes.
  • Bleeding disorders: Easy bruising, bleeding gums, nose bleeds, and excessive bleeding after surgery or accidents
  • Gastrointestinal problems: Diarrhea, weight loss, cramps, and blood in the stool
  • Pulmonary fibrosis (PF): A condition that affects the lungs and can lead to respiratory problems
  • joint pain

Diagnostic Tests

Diagnostic Tests for Hermansky-Pudlak Syndrome (HPS) 9

Hermansky-Pudlak Syndrome (HPS) is a rare genetic disorder that affects the production of melanin, leading to albinism, and also impacts blood clotting and other bodily systems. Diagnostic tests are essential to confirm the presence of HPS in individuals suspected of having the condition.

Clinical Molecular Genetics Test

A clinical molecular genetics test for Hermansky-Pudlak syndrome 9 is available, which involves deletion/duplication analysis, Next-Generation (NGS)/Massively parallel sequencing [1]. This test can establish or confirm the diagnosis by identifying mutations in the HPS genes.

Genetic Testing

Genetic testing for HPS can be performed to identify the specific genetic cause of the condition. The test covers 96% of the HPS genes at a 20x coverage rate and requires a blood sample (two 4ml tubes) [2].

Other Diagnostic Tests

While not specifically mentioned in the context, other diagnostic tests may include:

  • Electron microscopy to view prepared platelets
  • Commercial genetic testing for HPS
  • A 23 gene panel that includes assessment of non-coding variants, ideal for patients with a clinical suspicion of Hermansky-Pudlak Syndrome [5]

Diagnostic Criteria

The diagnosis of HPS is confirmed through molecular genetic testing, which shows mutations in the specific genes. Clinical findings of oculocut

Additional Diagnostic Tests

  • Genetic Testing
  • Electron microscopy
  • Clinical Molecular Genetics Test
  • 23 gene panel
  • Commercial genetic testing for HPS

Treatment

Current Drug Treatments for Hermansky-Pudlak Syndrome (HPS)

According to recent research, there are currently two clinically approved drugs for treating pulmonary fibrosis associated with HPS:

  • Nintedanib (Ofev): This drug inhibits receptor tyrosine kinases and has been shown to slow down the progression of pulmonary fibrosis in patients with HPS [9].
  • Pirfenidone (PFD): Another anti-fibrotic agent, pirfenidone has also been used to treat pulmonary fibrosis associated with HPS, although its effectiveness is still being researched and studied.

It's essential to note that these treatments are primarily focused on managing the symptoms of pulmonary fibrosis, which is a common complication of HPS. However, there may be other treatment options available for specific symptoms or complications related to HPS.

References: [9] by X Hu · 2024 — Nintedanib (Ofev) and pirfenidone (PFD) are currently two clinically approved drugs for treating pulmonary fibrosis.

Recommended Medications

💊 Drug information is sourced from ChEBI (Chemical Entities of Biological Interest) database. Always consult with a healthcare professional before starting any medication. Click on any medication name for detailed information.

Differential Diagnosis

Understanding Differential Diagnosis in Hermansky-Pudlak Syndrome

Hermansky-Pudlak syndrome (HPS) is a rare, hereditary disorder characterized by oculocutaneous albinism, bleeding diathesis, and other symptoms. When diagnosing HPS, it's essential to consider differential diagnosis, which involves ruling out other conditions that may present similar symptoms.

Key Considerations in Differential Diagnosis

  • Bleeding diathesis: This is a critical symptom of HPS, but it can also be caused by other conditions such as platelet disorders or coagulation factor deficiencies.
  • Pulmonary fibrosis: While pulmonary fibrosis is a feature of some types of HPS, it can also occur in other lung diseases.
  • Granulomatous colitis: This condition can mimic the gastrointestinal symptoms seen in HPS.

Differential Diagnosis Table

Condition Symptoms
Platelet disorders Bleeding diathesis, thrombocytopenia
Coagulation factor deficiencies Bleeding diathesis, prolonged bleeding times
Pulmonary fibrosis Shortness of breath, coughing, chest pain
Granulomatous colitis Abdominal pain, diarrhea, weight loss

Diagnosing HPS

To diagnose HPS, clinicians must consider the patient's clinical presentation, family history, and laboratory results. A diagnosis of HPS is typically made based on a combination of these factors.

  • Clinical findings: Oculocutaneous albinism, bleeding diathesis, and other symptoms.
  • Family history: A positive family history can suggest an inherited condition like HPS.
  • Laboratory results: Genetic testing can confirm the diagnosis of HPS.

Conclusion

Differential diagnosis is a critical aspect of diagnosing Hermansky-Pudlak syndrome. By considering other conditions that may present similar symptoms, clinicians can ensure accurate diagnosis and appropriate treatment for patients with HPS.

References:

  • [1] Hermansky-Pudlak syndrome (HPS) is characterized by oculocutaneous albinism, a bleeding diathesis, and, in some individuals, pulmonary fibrosis, ...
  • [5] Diagnosis is based on clinical findings of oculocutaneous albinism in combination with a bleeding diathesis, confirmed by an absence of platelet dense bodies ...
  • [9] by I Berber · Cited by 8 — HPS should be considered in the differential diagnosis in patients presenting with bleeding diathesis, when the clinical picture also includes ...

Additional Differential Diagnoses

Additional Information

rdf-schema#domain
https://w3id.org/def/predibionto#has_symptom_1567
owl#annotatedSource
t340871
oboInOwl#hasOBONamespace
disease_ontology
oboInOwl#id
DOID:0060547
core#notation
DOID:0060547
oboInOwl#hasDbXref
MIM:614171
IAO_0000115
A Hermansky-Pudlak syndrome that has_material_basis_in homozygous mutation in the gene encoding palladin (BLOC1S6) on chromosome 15q21.
rdf-schema#label
Hermansky-Pudlak syndrome 9
rdf-schema#subClassOf
http://purl.obolibrary.org/obo/DOID_3753
relatedICD
http://example.org/icd10/E70.331
22-rdf-syntax-ns#type
http://www.w3.org/2002/07/owl#Class

Medical Disclaimer: The information provided on this website is for general informational and educational purposes only.

It is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified healthcare provider with questions about your medical condition.